Your browser doesn't support javascript.
loading
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.
Kinzel, Megan; Dowhan, Michelle; Kalra, Amit; Williamson, Tyler S; Dabas, Rosy; Jamani, Kareem; Chaudhry, Ahsan; Shafey, Mona; Jimenez-Zepeda, Victor; Duggan, Peter; Daly, Andrew; Dharmani-Khan, Poonam; Khan, Faisal; Storek, Jan.
Afiliación
  • Kinzel M; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: megan.kinzel1@ucalgary.ca.
  • Dowhan M; Alberta Health Services, Calgary, Alberta, Canada.
  • Kalra A; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Williamson TS; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Dabas R; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Jamani K; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Chaudhry A; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Shafey M; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Jimenez-Zepeda V; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Duggan P; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Daly A; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
  • Dharmani-Khan P; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada; Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Khan F; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada; Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Storek J; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Health Services, Calgary, Alberta, Canada.
Transplant Cell Ther ; 28(1): 53.e1-53.e10, 2022 01.
Article en En | MEDLINE | ID: mdl-34607072
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article